Biotechnology Ionis gets a milestone approval; Another top FDA official to step down The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest FDA leader to leave the agency, and two biotechs cut research deals. Written by BioPharma Dive staff December 23, 2024December 23, 2024 Saving Bookmark this article Bookmarked
Biotechnology New patent for Vanda Pharms drug HETLIOZ Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in two NDAs. It is available from one supplier. There are thirty patents protecting this drug and two Paragraph IV challenges. Drug patent litigation for HETLIOZ. This drug has one […] Written by DrugPatentWatch – Make Better Decisions December 20, 2024December 20, 2024 Saving Bookmark this article Bookmarked
Biotechnology 10 biotech companies to watch in 2025 Newsletter Signup – Under Article / In Page “*” indicates required fields Last year, we documented nine biotechs we thought you should watch in 2024. Now, as the year has flown by and the end of 2024 is approaching, biotech companies will be setting out their plans for next year as they continue to work […] Written by Willow Shah-Neville December 16, 2024December 16, 2024 Saving Bookmark this article Bookmarked
Biotechnology Elevation Oncology Inc licences Synaffix BV’s ADC platform With the US$368m licence deal, Elevation Oncology, Inc is recognising Synaffix’s expertise in ADC development for the development of EO-1022. In contrast to Synaffix’s November deal with the Chinese BigHat Bioscience Co. Ltd, the US company does not book Lonza’s ADC manufacturing services that offers the same quality assurance process for all (clinicla) development phases, […] Written by Thomas Gabrielczyk December 13, 2024December 13, 2024 Saving Bookmark this article Bookmarked
Biotechnology ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH mid-stage findings for important new medicines. Written by Ned Pagliarulo, Jonathan Gardner and Ben Fidler December 10, 2024December 10, 2024 Saving Bookmark this article Bookmarked
Biotechnology Excipient Use in Biopharmaceuticals: Key Insights – ChemIntel360 Originally published at Get our excipient business reports at and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/ The biopharmaceutical industry has witnessed significant advancements over the past few decades, with excipients playing a crucial role in the formulation and stability of therapeutic drugs. Excipients, often considered the unsung heroes of drug development, are essential components that […] Written by ChemIntel360 December 6, 2024December 6, 2024 Saving Bookmark this article Bookmarked
Biotechnology A new era in immunotherapy Cancer vaccines represent an increasingly important area of biotech in oncology, using the body’s immune system to combat cancer cells. They are broadly categorized into two types: preventive and therapeutic vaccines. Preventive vaccines are designed to avert cancer development by targeting infections that can lead to cancer. Some examples of these are human papillomavirus (HPV) […] Written by Jules Adam December 3, 2024December 3, 2024 Saving Bookmark this article Bookmarked
Biotechnology Cradle Secures $73m Series B to Accelerate AI-Driven Protein Engineering Cradle, the pioneering platform for AI-powered protein engineering in Amsterdam, Netherlands, has successfully raised US$73m in Series B funding. The round, led by IVP with participation from existing investors Index Ventures and Kindred Capital, brings the company’s total funding to over US$100m. Cradle’s generative AI platform is already used across multiple industries, including pharmaceuticals, agriculture, […] Written by Georg Kääb November 30, 2024November 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark Shares in Amgen fell by double digits Tuesday on long-awaited results for the company’s monthly MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound. Written by Jonathan Gardner November 26, 2024November 26, 2024 Saving Bookmark this article Bookmarked
Biotechnology Which pharmaceutical drugs have the most drug patents in United Kingdom? Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ This chart shows the drugs with the most patents in United Kingdom. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. The companies with the greatest patent coverage in United Kingdom are: Onzetra Xsail Xhance Evzio Evzio (autoinjector) […] Written by DrugPatentWatch – Make Better Decisions November 23, 2024November 23, 2024 Saving Bookmark this article Bookmarked
Online Gambling Establishments that Accept Neteller: A Comprehensive Guide On the internet gambling establishments have actually revolutionized the betting sector, supplying comfort and accessibility to a wide array of games from the comfort of your own home. One of one of the most prominent repayment approaches used in on-line gambling establishments is Neteller. In this article, we will certainly check out the advantages Written by yam3t3 September 16, 2025September 16, 2025 Saving Bookmark this article Bookmarked
The purification of biomolecular condensates: Bottlenecks and strategies Biomolecular condensates are large assemblies of proteins and nucleic acids that form distinct compartments inside the cell without being surrounded by a membrane. They form through multivalent interactions, are not stereospecifically defined, and can scale with component addition. By concentrating specific biomolecules at specific times and cellular locations, condensates play key roles in many processes, […] Written by Admin September 16, 2025September 16, 2025 Saving Bookmark this article Bookmarked
Online Gambling Establishments that Accept Neteller: A Comprehensive Guide On the internet gambling establishments have actually revolutionized the betting sector, supplying comfort and accessibility to a wide array of games from the comfort of your own home. One of one of the most prominent repayment approaches used in on-line gambling establishments is Neteller. In this article, we will certainly check out the advantages Written by yam3t3 September 16, 2025September 16, 2025 Saving Bookmark this article Bookmarked
The purification of biomolecular condensates: Bottlenecks and strategies Biomolecular condensates are large assemblies of proteins and nucleic acids that form distinct compartments inside the cell without being surrounded by a membrane. They form through multivalent interactions, are not stereospecifically defined, and can scale with component addition. By concentrating specific biomolecules at specific times and cellular locations, condensates play key roles in many processes, […] Written by Admin September 16, 2025September 16, 2025 Saving Bookmark this article Bookmarked
Declaring war on the climate Military spending rises will increase these emissions. However, the exact relationship between military spending and military carbon emissions is highly complex and not easy to predict. For example, will extra funding be mainly used to increase military activity, leading to rises in fossil fuel use by combat planes or warships? Or will the funding be […] Written by brendan September 16, 2025September 16, 2025 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked